ArticleCancer chemotherapy and pharmacology2025
6-gingerol alleviates chemotherapy-induced nausea and vomiting by inhibiting ferroptosis via the regulation of iron homeostasis.
Article in Cancer chemotherapy and pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Progress in traditional Chinese medicine for chemotherapy-induced nausea and vomiting, based on the theory of "Fuzheng Quxie" and "Hewei Jiangni".American journal of translational research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeChemotherapy-induced nausea and vomiting (CINV) is a common gastrointestinal side effect in cancer treatment. 6-gingerol, a bioactive component of ginger, demonstrates efficacy in attenuating CINV. This study aimed to explore the effects of 6-gingerol on inhibiting ferroptosis and to clarify its potential antiemetic mechanisms in a cisplatin-induced rat pica model.
methodsWe established the rat pica model by intraperitoneal injection of cisplatin (6 mg/kg). The histopathological damage in gastrointestinal (GI) tissues was assessed by hematoxylin-eosin staining. The levels of serum IL-6, IL-1β, TNF-α, and hepcidin were measured by ELISA. The occurrence of ferroptosis was confirmed by measuring the levels of ROS, GSH, SOD, MDA, and iron in GI tissues. Furthermore, iron deposition was visualized with Perls + DAB staining, and the lipid peroxidation product 4-HNE was detected via immunohistochemistry. The expression levels of iron homeostasis-related proteins in GI tissues were examined by western blotting.
resultsThe results showed that 6-gingerol improved pica behavior and mitigated GI inflammation in cisplatin-treated rats. Additionally, 6-gingerol mitigated oxidative stress, lipid peroxidation, and reduced iron accumulation. Molecular docking analysis showed that iron homeostasis-related proteins (TfR1, DMT1, ferritin, Fpn, and hepcidin) might be the potential regulatory targets of 6-gingerol. Mechanistically, 6-gingerol restored iron homeostasis by downregulating the expression levels of TfR1 and DMT1 to reduce iron uptake and transport, and upregulating the expression levels of ferritin and Fpn to enhance iron storage and export.
conclusionOverall, this study indicates that regulating iron homeostasis to inhibit ferroptosis is related to the therapeutic effect of 6-gingerol against CINV.
Indexed as
Identifiers
41335238What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.